SG10202009020VA - New 2' and/or 5' amino-acid ester phosphoramidate 3'-deoxy adenosine derivatives as anti-cancer compounds - Google Patents

New 2' and/or 5' amino-acid ester phosphoramidate 3'-deoxy adenosine derivatives as anti-cancer compounds

Info

Publication number
SG10202009020VA
SG10202009020VA SG10202009020VA SG10202009020VA SG10202009020VA SG 10202009020V A SG10202009020V A SG 10202009020VA SG 10202009020V A SG10202009020V A SG 10202009020VA SG 10202009020V A SG10202009020V A SG 10202009020VA SG 10202009020V A SG10202009020V A SG 10202009020VA
Authority
SG
Singapore
Prior art keywords
amino
new
acid ester
cancer compounds
adenosine derivatives
Prior art date
Application number
SG10202009020VA
Other languages
English (en)
Inventor
Hugh Griffith
Christopher Mcguigan
Valentina Ferrari
Michaela Serpi
Antunez Carmen Jimenez
Original Assignee
NuCana plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=54771155&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SG10202009020V(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GBGB1421211.2A external-priority patent/GB201421211D0/en
Priority claimed from GBGB1519316.2A external-priority patent/GB201519316D0/en
Application filed by NuCana plc filed Critical NuCana plc
Publication of SG10202009020VA publication Critical patent/SG10202009020VA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C07H19/173—Purine radicals with 2-deoxyribosyl as the saccharide radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C07H19/20—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C07H19/20—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
    • C07H19/207—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids the phosphoric or polyphosphoric acids being esterified by a further hydroxylic compound, e.g. flavine adenine dinucleotide or nicotinamide-adenine dinucleotide
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
SG10202009020VA 2014-11-28 2015-11-27 New 2' and/or 5' amino-acid ester phosphoramidate 3'-deoxy adenosine derivatives as anti-cancer compounds SG10202009020VA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1421211.2A GB201421211D0 (en) 2014-11-28 2014-11-28 Chemical compounds
GBGB1519316.2A GB201519316D0 (en) 2015-11-02 2015-11-02 Chemical compounds

Publications (1)

Publication Number Publication Date
SG10202009020VA true SG10202009020VA (en) 2020-10-29

Family

ID=54771155

Family Applications (2)

Application Number Title Priority Date Filing Date
SG10202009020VA SG10202009020VA (en) 2014-11-28 2015-11-27 New 2' and/or 5' amino-acid ester phosphoramidate 3'-deoxy adenosine derivatives as anti-cancer compounds
SG11201702369UA SG11201702369UA (en) 2014-11-28 2015-11-27 New 2' and/or 5' amino-acid ester phosphoramidate 3'-deoxy adenosine derivatives as anti-cancer compounds

Family Applications After (1)

Application Number Title Priority Date Filing Date
SG11201702369UA SG11201702369UA (en) 2014-11-28 2015-11-27 New 2' and/or 5' amino-acid ester phosphoramidate 3'-deoxy adenosine derivatives as anti-cancer compounds

Country Status (25)

Country Link
US (3) US10570168B2 (me)
EP (2) EP3224268B1 (me)
JP (2) JP6646668B2 (me)
KR (2) KR20230098915A (me)
CN (2) CN107207554B (me)
AU (2) AU2015352203B2 (me)
CA (1) CA2962373C (me)
CL (1) CL2017001336A1 (me)
CY (1) CY1122074T1 (me)
DK (1) DK3224268T3 (me)
EA (1) EA031727B1 (me)
ES (1) ES2742167T3 (me)
HR (1) HRP20191461T1 (me)
HU (1) HUE046850T2 (me)
IL (4) IL291927A (me)
LT (1) LT3224268T (me)
ME (1) ME03462B (me)
MX (3) MX2020010375A (me)
PH (1) PH12017500944A1 (me)
PL (1) PL3224268T3 (me)
PT (1) PT3224268T (me)
RS (1) RS59264B1 (me)
SG (2) SG10202009020VA (me)
SI (1) SI3224268T1 (me)
WO (1) WO2016083830A1 (me)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2828326C (en) 2011-03-01 2019-05-07 Nucana Biomed Limited Phosphoramidate derivatives of 5 - fluoro - 2' - deoxyuridine for use in the treatment of cancer
ES2742167T3 (es) * 2014-11-28 2020-02-13 NuCana plc Nuevos derivados éster 2' y/o 5' de fosforamidato de aminoácidos de la 3'-desoxiadenosina como compuestos anticancerígenos
GB201522764D0 (en) * 2015-12-23 2016-02-03 Nucana Biomed Ltd Formulations of phosphate derivatives
GB201609600D0 (en) 2016-06-01 2016-07-13 Nucuna Biomed Ltd Cancer treatments
GB201609601D0 (en) * 2016-06-01 2016-07-13 Nucana Biomed Ltd Phosphoramidate compounds
GB201709471D0 (en) * 2017-06-14 2017-07-26 Nucana Biomed Ltd Diastereoselective synthesis of hosphate derivatives
GB201720279D0 (en) * 2017-12-05 2018-01-17 Nucana Biomed Ltd Anticancer compounds
CN110669088B (zh) * 2018-07-02 2023-03-28 成都阿奇生物医药科技有限公司 N-(2-乙基胺)苯磺酰胺基虫草素衍生物及其制备方法和应用
GB201904544D0 (en) 2019-04-01 2019-05-15 NuCana plc Anticancer compounds
CN111888373A (zh) * 2019-05-05 2020-11-06 上海医药集团股份有限公司 一种虫草素或其药学上可接受的盐的应用
WO2023218202A2 (en) 2022-05-12 2023-11-16 NuCana plc Cancer treatment
CN116768949A (zh) * 2022-07-12 2023-09-19 南京工业大学 一种基于3’-脱氧腺苷经化学修饰改性的具有抗癌效应的化合物

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4357324A (en) 1981-02-24 1982-11-02 The United States Of America As Represented By The Department Of Health And Human Services Prodrug derivatives of 9β-D-arabinofuranosyl-2-fluoroadenine
GB0317009D0 (en) 2003-07-21 2003-08-27 Univ Cardiff Chemical compounds
EP1827460A4 (en) * 2004-12-09 2012-03-14 Univ Minnesota NUCLEOSIDE WITH ANTIVIRAL AND ANTI-CANCER EFFECT
GB0505781D0 (en) 2005-03-21 2005-04-27 Univ Cardiff Chemical compounds
WO2006121820A1 (en) * 2005-05-05 2006-11-16 Valeant Research & Development Phosphoramidate prodrugs for treatment of viral infection
GB0623493D0 (en) 2006-11-24 2007-01-03 Univ Cardiff Chemical compounds
KR20110120886A (ko) 2009-01-09 2011-11-04 유니버시티 칼리지 오브 카디프 컨설턴트 리미티드 바이러스 감염 치료용 구아노신 뉴클레오사이드 화합물의 포스포라미데이트 유도체
CN102395590A (zh) * 2009-02-06 2012-03-28 Rfs制药公司 用于治疗癌症和病毒感染的嘌呤核苷单磷酸酯前药
JP2012521359A (ja) * 2009-03-20 2012-09-13 アリオス バイオファーマ インク． 置換されたヌクレオシドアナログおよびヌクレオチドアナログ
JP5937073B2 (ja) 2010-07-19 2016-06-22 ギリード・サイエンシズ・インコーポレーテッド ジアステレオマーとして純粋なホスホルアミデートプロドラッグの調製方法
GEP20156313B (en) 2010-09-22 2015-07-10 Alios Biopharma Inc Substituted nucleotide analogs
US20120070411A1 (en) * 2010-09-22 2012-03-22 Alios Biopharma, Inc. Substituted nucleotide analogs
GB201016855D0 (en) 2010-10-06 2010-11-17 Nucana Biomed Ltd Chemical compounds
CA2828326C (en) 2011-03-01 2019-05-07 Nucana Biomed Limited Phosphoramidate derivatives of 5 - fluoro - 2' - deoxyuridine for use in the treatment of cancer
US20140286903A1 (en) * 2011-11-10 2014-09-25 Inhibitex, Inc. Substituted Purine Nucleosides, Phosphoramidate and Phosphordiamidate Derivatives for Treatment if Viral Infections
WO2015038596A1 (en) 2013-09-11 2015-03-19 Emory University Nucleotide and nucleoside compositions and uses related thereto
EP3074411A2 (en) 2013-11-27 2016-10-05 Idenix Pharmaceuticals LLC Nucleotides for the treatment of liver cancer
MX2016015629A (es) 2014-06-25 2017-08-02 Nucana Biomed Ltd Formulacion que comprende un profarmaco de gemcitabina.
CN105646629A (zh) 2014-11-25 2016-06-08 广州市恒诺康医药科技有限公司 L-核苷类化合物及其应用
ES2742167T3 (es) * 2014-11-28 2020-02-13 NuCana plc Nuevos derivados éster 2' y/o 5' de fosforamidato de aminoácidos de la 3'-desoxiadenosina como compuestos anticancerígenos
WO2016145142A1 (en) 2015-03-10 2016-09-15 Emory University Nucleotide and nucleoside therapeutics compositions and uses related thereto
MX2020009154A (es) 2015-05-14 2022-03-08 NuCana plc Nuc-1031 (gemcitabina-[fenil-benzoxi-l-alaninil])-fosfato) para usarse en el tratamiento neoadyuvante y adyuvante en pacientes con cáncer.
GB201522764D0 (en) 2015-12-23 2016-02-03 Nucana Biomed Ltd Formulations of phosphate derivatives
GB201609600D0 (en) 2016-06-01 2016-07-13 Nucuna Biomed Ltd Cancer treatments
GB201609601D0 (en) 2016-06-01 2016-07-13 Nucana Biomed Ltd Phosphoramidate compounds
GB201609602D0 (en) 2016-06-01 2016-07-13 Nucuna Biomed Ltd Chemical compounds
GB201709471D0 (en) 2017-06-14 2017-07-26 Nucana Biomed Ltd Diastereoselective synthesis of hosphate derivatives

Also Published As

Publication number Publication date
EP3224268A1 (en) 2017-10-04
BR112017011187A2 (pt) 2018-01-02
CN111909231A (zh) 2020-11-10
IL251353B (en) 2020-08-31
US20170253629A1 (en) 2017-09-07
MX2022008744A (es) 2022-07-27
DK3224268T3 (da) 2019-09-02
US20220306675A1 (en) 2022-09-29
MX2020010375A (es) 2022-07-19
NZ767066A (en) 2022-03-25
PH12017500944A1 (en) 2017-11-20
KR102548806B1 (ko) 2023-06-27
AU2019232929A1 (en) 2019-10-10
CA2962373C (en) 2023-04-25
IL292062B2 (en) 2023-06-01
IL291927A (en) 2022-06-01
NZ730919A (en) 2021-02-26
EA201791182A1 (ru) 2017-09-29
IL276109B (en) 2022-05-01
AU2015352203A1 (en) 2017-04-27
IL251353A0 (en) 2017-05-29
KR20230098915A (ko) 2023-07-04
EP3224268B1 (en) 2019-06-26
ES2742167T3 (es) 2020-02-13
JP6646668B2 (ja) 2020-02-14
HRP20191461T1 (hr) 2019-11-15
US20200181189A1 (en) 2020-06-11
CA2962373A1 (en) 2016-06-02
ME03462B (me) 2020-01-20
AU2015352203B2 (en) 2019-08-15
SG11201702369UA (en) 2017-04-27
IL292062A (en) 2022-06-01
US11352387B2 (en) 2022-06-07
WO2016083830A1 (en) 2016-06-02
MX2017006942A (es) 2017-08-24
EP3683225A1 (en) 2020-07-22
IL276109A (en) 2020-08-31
AU2019232929B2 (en) 2020-09-10
EA031727B1 (ru) 2019-02-28
KR20170087465A (ko) 2017-07-28
US10570168B2 (en) 2020-02-25
SI3224268T1 (sl) 2019-10-30
PL3224268T3 (pl) 2019-11-29
RS59264B1 (sr) 2019-10-31
HUE046850T2 (hu) 2020-03-30
JP6978524B2 (ja) 2021-12-08
PT3224268T (pt) 2019-09-04
JP2020075928A (ja) 2020-05-21
JP2017535587A (ja) 2017-11-30
CN107207554B (zh) 2020-09-11
CN107207554A (zh) 2017-09-26
CY1122074T1 (el) 2020-11-25
CL2017001336A1 (es) 2017-12-15
LT3224268T (lt) 2019-09-25

Similar Documents

Publication Publication Date Title
IL292062A (en) New histories of 2' and/or 5' amino acid ester phosphoramidate 3'-deoxy adenosine as anticancer compounds
ZA201705092B (en) Substituted nucleoside derivatives useful as anticancer agents
HK1244007A1 (zh) 5'-取代的核苷類似物
IL263121B (en) History of nucleoside phosphoramidate as anticancer agents
EP3277381A4 (en) Nitrobenzyl derivatives of anti-cancer agents
EP3464313A4 (en) MODIFIED NUCLEOTIDES 5 '-CYCLO-PHOSPHONATE
ZA201801465B (en) 3-phenyl-benzofuran-2-one derivatives containing phosphorus as stabilizers
HK1255108A1 (zh) 核苷類藥物的氨基磷酸酯衍生物的製劑
IL249581A0 (en) History of isoindolinones used as antiviral agents
EP3172324A4 (en) 5'-triphosphate oligoribonucleotides
IL291574A (en) Methods for using 5-adenosine diphosphate ribose (adpr)
EP3448392A4 (en) ALCYNE-CONTAINING NUCLEOTIDES AND NUCLEOSIDES THERAPEUTIC COMPOSITIONS AND USES THEREOF
EP3402536A4 (en) RADIOACTIVELY MARKED ERLOTINIB ANALOGUES AND USES THEREOF
GB201522591D0 (en) Improvements in or relating to corona shields
GB201520081D0 (en) Improvements in or relating to pouches
GB201408137D0 (en) Improvements in or relating to mine ploughs
HUP1700542A2 (en) Nucleosides modified by 5'-linker
GB2556887B (en) Improvements in or relating to hangers
GB2545638B (en) Improvements in or relating to mine ploughing
GB2545716B (en) Improvements in or relating to the separation of radon
GB201518012D0 (en) Improvements in or relating to tilling
AU2015904137A0 (en) Method to Protect 2
GB201505220D0 (en) Improvements in or relating to planters